Dergiler / Turkish Journal of Anaesthesiology and Reanimation / 2020 / Cilt: 48 - Sayı: 1

Effectiveness of the Analgesia Nociception Index Monitoring in Patients Who Undergo Colonoscopy with Sedo-Analgesia

Sayfa
50–57
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Further studieswith longer procedure times and with a greater number of patients are required to demonstrate whether there is a difference in side effectsand recovery times.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The objective of this study was to improve the patient comfort and safety during procedures done under anaesthesia and sedation.
📊
Temel Bulgular & Veri:We aimed to compare the effects of analgesia management with conventional methods and with ANImonitoring on total opioid consumption, sedation and analgesia levels in patients who underwent colonoscopy using sedo-analgesia.Methods: Adult patients (n=102), scheduled for procedural sedation, were prospectively analysed.
💡
Sonuç & Katkı:Further studieswith longer procedure times and with a greater number of patients are required to demonstrate whether there is a difference in side effectsand recovery times.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The objective of this study was to improve the patient comfort and safety during procedures done under anaesthesia and sedation. The analgesia nociception index (ANI) noninvasively provides information on the nociception-antinociception balance, and it can beused to assess analgesia objectively. We aimed to compare the effects of analgesia management with conventional methods and with ANImonitoring on total opioid consumption, sedation and analgesia levels in patients who underwent colonoscopy using sedo-analgesia.Methods: Adult patients (n=102), scheduled for procedural sedation, were prospectively analysed. After the induction with propofol andketamine, infusions of propofol (2 mg kg−1 h−1) and remifentanil (0.05 mcg kg−1 min−1) were started. In Group A, remifentanil infusions weretitrated to maintain the ANI value between 50 and 70, whereas in Group C, analgesic requirements were met according to the attendinganaesthetist’s intention. The heart rate, blood pressure, respiratory rate, SpO2, BIS, Numeric Rating Scale (NRS) and Ramsay SedationScale were monitored. Complications, analgesics consumption, duration of the procedure, demographic information, NRS and the ModifiedAldrete Score were evaluated.Results: A total remifentanil amount used in Group A was 66.51±47.87 mcg and 90.15±58.17 mcg in Group C (p=0.011); there was nodifference in total amounts of ketamine and propofol given. There was a negative correlation between ANI and NRS scores of Group Apatients at Minute 0 at the level of 0.402, which was significant statistically (p=0.003).Conclusion: Opioid consumption was diminished when ANI monitoring was used, and thus the patient safety was improved. Further studieswith longer procedure times and with a greater number of patients are required to demonstrate whether there is a difference in side effectsand recovery times.

🔖

Bu Makaleye Atıf Yap

SORAL, M., ALTUN, G. T., DİNÇER, P. C., ARSLANTAŞ, M. K., AYKAÇ, Z. (2020). Effectiveness of the Analgesia Nociception Index Monitoring in Patients Who Undergo Colonoscopy with Sedo-Analgesia. Turkish Journal of Anaesthesiology and Reanimation, Cilt: 48 - Sayı: 1, 50–57. https://ajindex.com/articles/370082

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Van De Velde M, Kuypers M, Teunkens A, Devroe S. Risk and safety of anesthesia outside the operating room. Minerva Anestesiologica 2009; 75: 345-8
  2. Chelazzi C, Consales G, Boninsegni P, Bonanomi GA, Castiglione G, De Gaudio AR. Propofol sedation in a colorectal cancer screening outpatient cohort. Minerva Anestesiologica 2009; 75: 677-83
  3. World Health Organization. Promoting rational use of medicines: core components. WHO Policy Perspectives on Medicines. No: 005. September 2002. Available from: http://apps. who.int/medicinedocs/pdf/h3011e/h3011e.pdf
  4. Gruenewald M, Ilies C. Monitoring the nociception-anti-nociception balance. Best Practice & Research Clinical Anaesthesiology 2013; 27: 235-47. [CrossRef] 5. Logier R, Jeanne M, De Jonckheere J, Dassonneville A, Delecroix M, Tavernier B. PhysioDoloris: a monitoring device for analgesia / nociception balance evaluation using heart rate variability analysis. Conference proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference; 2010 31 August-4 Semptember, Buenos Aires: Argentina, pp:1194-7. [CrossRef] 6. Boselli E, Bouvet L, Begou G, Torkmani S, Allaouchiche B. Prediction of hemodynamic reactivity during total intravenous anesthesia for suspension laryngoscopy using analgesia/nociception index (ANI): a prospective observational study. Minerva Anestesiologica 2015; 81: 288-97
  5. Boselli E, Daniela-Ionescu M, Begou G, Dabouz R, Davidson J, Deloste JY et al. Prospective observational study of the non-invasive assessment of immediate postoperative pain using the analgesia/nociception index (ANI). Br J Anaest 2013; 111: 453- 9. [CrossRef] 8. Jeanne M, Logier R, De Jonckheere J, Tavernier B. Heart rate variability during total intravenous anesthesia: effects of nociception and analgesia. Auton Neurosci 2009; 147: 91-6. [CrossRef] 9. Rudner R, Jalowiecki P, Kawecki P, Gonciarz M, Mularczyk A, Petelenz M. Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy. Gastrointest Endosc 2003; 57: 657-63. [CrossRef] 10. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013.
  6. Bellolio MF, Gilani WI, Barrionuevo P, Murad MH, Erwin PJ, Anderson JR, et al. Incidence of adverse events in adults undergo